.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
US Department of Justice
Dow
Medtronic
Healthtrust
Mallinckrodt
QuintilesIMS
Accenture
Fish and Richardson

Generated: July 23, 2017

DrugPatentWatch Database Preview

AZULFIDINE Drug Profile

« Back to Dashboard

What is the patent landscape for Azulfidine, and what generic Azulfidine alternatives are available?

Azulfidine is a drug marketed by Pharmacia And Upjohn and is included in three NDAs.

The generic ingredient in AZULFIDINE is sulfasalazine. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

Summary for Tradename: AZULFIDINE

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list77
Clinical Trials: see list1
Patent Applications: see list5,298
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AZULFIDINE at DailyMed

Pharmacology for Tradename: AZULFIDINE

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
AZULFIDINE
sulfasalazine
SUSPENSION;ORAL018605-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
AZULFIDINE EN-TABS
sulfasalazine
TABLET, DELAYED RELEASE;ORAL007073-002Apr 6, 1983ABRXYesYes► Subscribe► Subscribe
Pharmacia And Upjohn
AZULFIDINE
sulfasalazine
TABLET;ORAL007073-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Pharmacia And Upjohn
AZULFIDINE
sulfasalazine
SUSPENSION;ORAL086983-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Citi
Julphar
Cerilliant
McKesson
Johnson and Johnson
Farmers Insurance
QuintilesIMS
Harvard Business School
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot